Intranasal Administration of Genetically Modified Lactococcus Lactis Producing PD-L1 scFv Improves Survival in Lung Cancer Model Mice

被引：0
|
作者：
Nomura, N. [1 ]
Namai, F. [1 ]
Sato, T. [1 ]
Shimosato, T. [1 ]
机构：
[1] Shinshu Univ, Inst Biomed Sci, Nagano, Japan
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2023年 / 207卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A5754
引用
收藏
页数：1
相关论文
共 50 条
  • [1] PD-L1 Status and Survival in Patients With Lung Cancer Reply
    Miller, Peter Grant
    Li, Gerald
    Singal, Gaurav
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2019, 322 (08): : 783 - 784
  • [2] Sequential administration of pemetrexed and cisplatin reprograms tumor immune microenvironment and potentiates PD-1/PD-L1 treatment in a lung cancer model
    Yu, Jinxiang
    Zhang, Qianyun
    Li, Jie
    Si, Zhaohui
    Guo, Yuanyuan
    Xu, Xin
    Wu, Kanjin
    JOURNAL OF INVESTIGATIVE MEDICINE, 2022, 70 (03) : 792 - 799
  • [3] PD-L1 and C-MET Expression and Survival in Patients with Small Cell Lung Cancer
    Miao, Lulu
    Fan, Yun
    Lu, Yunyun
    Xu, Yanjun
    Huang, Zhiyu
    Gong, Lei
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S360 - S361
  • [4] Cellular Expression of PD-L1 in the Peripheral Blood of Lung Cancer Patients is Associated with Worse Survival
    Boffa, Daniel J.
    Graf, Ryon P.
    Salazar, Michelle C.
    Hoag, Jessica
    Lu, David
    Krupa, Rachel
    Louw, Jessica
    Dugan, Lyndsey
    Wang, Yipeng
    Landers, Mark
    Suraneni, Mahipal
    Greene, Stephanie B.
    Magana, Marisa
    Makani, Samir
    Bazhenova, Lyudmila
    Dittamore, Ryan V.
    Nieva, Jorge
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2017, 26 (07) : 1139 - 1145
  • [5] PD-L1 and c-MET expression and survival in patients with small cell lung cancer
    Miao, Lulu
    Lu, Yunyun
    Xu, Yanjun
    Zhang, Gu
    Huang, Zhiyu
    Gong, Lei
    Fan, Yun
    ONCOTARGET, 2017, 8 (33) : 53978 - 53988
  • [6] Emergence of lung cancer with a low PD-L1 expression level after the administration of immune check point inhibitor for lung adenocarcinoma with a high PD-L1 expression level: A case report
    Iwai, Shun
    Funasaki, Aika
    Sekimura, Atsushi
    Motono, Nozomu
    Usuda, Katsuo
    Yamada, Sohsuke
    Ueda, Yoshimichi
    Akasaki, Kyouta
    Tanimura, Kouta
    Kase, Kazumasa
    Uramoto, Hidetaka
    ANNALS OF MEDICINE AND SURGERY, 2020, 56 : 82 - 85
  • [7] 89Zr-Df-anti-PD-L1 for evaluating in vivo PD-L1 level in lung cancer mouse model
    Geller, Anne
    Yan, Jun
    Guo, Haixun
    JOURNAL OF NUCLEAR MEDICINE, 2018, 59
  • [8] PD-L1 expression and survival in patients with non-small cell lung cancer (NSCLC) in Korea
    Sun, Jong-Mu
    Zhou, Wei
    Choi, Yoon-La
    Choi, So-Jung
    Kim, Se Eun
    Wang, Zhen
    Dolled-Filhart, Marisa
    Emancipator, Kenneth
    Weiner, Russell
    Park, Minjin
    Kim, Hong Kwan
    Choi, Yong Soo
    Shim, Young Mog
    Kim, Jhingook
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [9] PD-L1 Expression Level Could Predict the Survival of Patients with Resectable Small Cell Lung Cancer
    Jing, Wang
    Wang, Haiyong
    An, Changchun
    Yu, Jinming
    Zhu, Hui
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1484 - S1485
  • [10] Maintaining hepatic PD-L1 expression improves sepsis survival in a murine polymicrobial sepsis model by tolerizing CTL
    Knethen, A.
    Schaefer, A.
    Kuchler, L.
    Knape, T.
    Christen, U.
    Hintermann, E.
    Fisslthaler, B.
    Schroeder, K.
    Brandes, R. P.
    Genz, B.
    Abshagen, K.
    Puetzer, B. M.
    Sha, L. K.
    Weigert, A.
    Syed, S. N.
    Schulz, M.
    Shah, A. M.
    Ernst, A.
    Putyrski, M.
    Finkelmeier, F.
    Pesic, M.
    Greten, F.
    Hoghardt, M.
    Kempf, V. A. J.
    Gunne, S.
    Parnham, M. J.
    Bruece, B.
    INFECTION, 2019, 47 : S21 - S21
12345